Skip to content

Clinical trials

Phase 3 Autoimmune Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 3 Country / region: Canada Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20082
20091
20102
20112
20121
20131
20151
20211
20221
20232
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Recruiting5
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Human Genome Sciences Inc., a GSK Company3
Eli Lilly and Company2
Novartis Pharmaceuticals2
Amgen1
AstraZeneca1
Baxalta now part of Shire1
Bristol-Myers Squibb1
Fred Lublin1
GlaxoSmithKline1
Human Genome Sciences Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases21
Immune System Diseases9
Lupus Erythematosus, Systemic7
Connective Tissue Diseases5
Arthritis, Rheumatoid3
Arthritis2
Autoimmune Diseases of the Nervous System2
Demyelinating Diseases2
Glomerulonephritis2
Joint Diseases2

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.